» Articles » PMID: 32555634

Epidemiology of Hepatitis B and C Virus Infections Among Patients Who Booked for Surgical Procedures at Felegehiwot Referral Hospital, Northwest Ethiopia

Overview
Journal PLoS One
Date 2020 Jun 20
PMID 32555634
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hepatitis B virus(HBV) and hepatitis C virus(HCV) are the main causes of cirrhosis, liver cancer, and death. This study aimed to determine the seroprevalence and associated factors of HBV surface antigen(HBsAg) and anti-HCV among patients screened for surgery at Felegehiwot referral hospital, Northwest Ethiopia.

Methods: A hospital-based cross-sectional study was conducted among 433 patients in 2018. Data on socio-demographic and risk factors were collected by an exit interview using a pretested structured questionnaire. A venous blood sample of 5ml was collected from each participant, and serum was tested for HBsAg and anti-HCV using one-step rapid test kits and enzyme-linked immunosorbent assay. Multivariable logistic regression analysis was computed to identify factors associated with HBV and HCV infections. The odds ratio with 95%CI was used to describe the strength of association and statistical significance.

Results: A total of 422 patients gave data and included in the analysis. The mean age of patients was 36±5 years. About two-thirds, 269(64%) and 274(65%) patients were males, and from rural areas, respectively. The seroprevalence of HBsAg was 34(8%) followed by 18(4.3%) anti-HCV and 4(0.9%) co-infections. Being single(AOR = 1.96, 95%CI = 1.12-3.10), rural residence (AOR = 2.68, 95%CI = 1.28-5.61), ever heard about HBV (AOR = 2.41, 95%CI = 1.18-5.20), having multiple sexual partners(AOR = 2.85, 95%CI = 1.30-5.58), HIV positive(AOR = 3.14, 95%CI = 1.31-7.61), history of tooth extraction(AOR = 3.0, 95%CI = 1.40-6.56), hospitalization history(AOR = 2.95, 95%CI = 1.26-5.81), sharing of sharp instruments (AOR = 3.86, 95%CI = 1.82-8.79), and had blood contact(AOR = 2.64, 95%CI = 1.14-5.42) were statistically significant factors to HBV infection. Similarly, sharing of sharp instruments(AOR = 4.65, 95%CI = 1.32-15.1), tooth extraction practice(AOR = 2.81, 95%CI = 1.12-6.56), surgical history (AOR = 3.68, 95%CI = 1.64-9.82), hospitalization history(AOR = 4.51, 95%CI = 1.62-8.35) and had blood contact(AOR = 3.2, 95%CI = 1.56-8.51) were significant factors to HCV infection.

Conclusion: The seroprevalence of HBsAg and ant-HCV was high compared to WHO and previous study findings. Giving special attention to awareness creation, rural settings, improving personal behaviors, infection prevention activities of health facilities, quality of healthcare procedures is crucial to prevent viral hepatitis infection.

Citing Articles

Molecular epidemiology and genetic characterization of hepatitis B virus in two major provinces of Pakistan.

Almas I, Tariq S, Amin I, Shahid M, Idrees M, Afzal S Arch Virol. 2024; 169(11):239.

PMID: 39499382 DOI: 10.1007/s00705-024-06163-8.


Seroprevalence of hepatitis B and hepatitis C virus among clinically suspected cases of viral hepatitis visiting Guhalla Primary Hospital, Northwest Ethiopia.

Belete D, Fekadie E, Kassaw M, Fenta M, Jegnie A, Mulu T Sci Rep. 2024; 14(1):21956.

PMID: 39304682 PMC: 11415349. DOI: 10.1038/s41598-024-71363-w.


Seroprevalence of hepatitis B and C viruses and some possible associated factors among cancer patients at the Oncology Treatment Center, Gondar, Northwest Ethiopia: A cross-sectional study.

Atanaw T, Girmay G, Zemene A, Assefa M, Eshetie T, Bewket G PLoS One. 2024; 19(8):e0308161.

PMID: 39093829 PMC: 11296633. DOI: 10.1371/journal.pone.0308161.


Seroprevalence of hepatitis B, C, and its associated risk factors among clinically suspected patients attending poly and Maraki Health Centers, Gondar City, North West Ethiopia.

Tesfaye S, Alemu A, Bizualem E, Mehabie D, Alelign A SAGE Open Med. 2024; 12:20503121241266347.

PMID: 39092161 PMC: 11292706. DOI: 10.1177/20503121241266347.


Prevalence of hepatitis B virus infection among pregnant women in Africa: A systematic review and meta-analysis.

Larebo Y, Anshebo A, Abdo R, Behera S, Gopalan N PLoS One. 2024; 19(7):e0305838.

PMID: 39012904 PMC: 11251621. DOI: 10.1371/journal.pone.0305838.


References
1.
Kramvis A, Kew M . Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatol Res. 2007; 37(s1):S9-S19. DOI: 10.1111/j.1872-034X.2007.00098.x. View

2.
Woldegiorgis A, Erku W, Medhin G, Berhe N, Legesse M . Community-based sero-prevalence of hepatitis B and C infections in South Omo Zone, Southern Ethiopia. PLoS One. 2019; 14(12):e0226890. PMC: 6936792. DOI: 10.1371/journal.pone.0226890. View

3.
Yazie T, Tebeje M . An updated systematic review and meta-analysis of the prevalence of hepatitis B virus in Ethiopia. BMC Infect Dis. 2019; 19(1):917. PMC: 6820955. DOI: 10.1186/s12879-019-4486-1. View

4.
Hofstraat S, Falla A, Duffell E, Hahne S, Amato-Gauci A, Veldhuijzen I . Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review. Epidemiol Infect. 2017; 145(14):2873-2885. PMC: 5647665. DOI: 10.1017/S0950268817001947. View

5.
Liu W, Liu Q . Molecular mechanisms of gender disparity in hepatitis B virus-associated hepatocellular carcinoma. World J Gastroenterol. 2014; 20(20):6252-61. PMC: 4033463. DOI: 10.3748/wjg.v20.i20.6252. View